Arbutus Biopharma Reports Positive Phase 2a Results for Imdusiran in Combination with VTP-300 and Low Dose Nivolumab in Chronic Hepatitis B Patients at EASL 2025
7/5 08:10
Imdusiran combined with VTP-300 and nivolumab shows promise for achieving functional cures in chronic hepatitis B patients....